These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases. Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120 [TBL] [Abstract][Full Text] [Related]
7. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Herskovic T; Hanley D; Markowitz A; Dunn R; Siegel J; Kamal T; Goldenberg DM J Clin Oncol; 1996 Apr; 14(4):1209-17. PubMed ID: 8648376 [TBL] [Abstract][Full Text] [Related]
8. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments. O'Byrne KJ; Hamilton D; Robinson I; Sweeney E; Freyne PJ; Cullen MJ Nucl Med Commun; 1992 Mar; 13(3):142-8. PubMed ID: 1557212 [TBL] [Abstract][Full Text] [Related]
9. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease. Mendelsohn G; Wells SA; Baylin SB Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353 [TBL] [Abstract][Full Text] [Related]
10. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique. Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771 [TBL] [Abstract][Full Text] [Related]
11. Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. Manil L; Boudet F; Motte P; Gardet P; Saccavini JC; Lumbroso JD; Schlumberger M; Caillou B; Bazin JP; Ricard M Cancer Res; 1989 Oct; 49(19):5480-5. PubMed ID: 2766309 [TBL] [Abstract][Full Text] [Related]
12. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report. O'Driscoll CM; Baker F; Casey MJ; Duffy GJ J Nucl Med; 1991 Dec; 32(12):2281-3. PubMed ID: 1744716 [TBL] [Abstract][Full Text] [Related]
13. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma. Sandrock D; Blossey HC; Steinroeder M; Munz DL Henry Ford Hosp Med J; 1989; 37(3-4):173-4. PubMed ID: 2576957 [TBL] [Abstract][Full Text] [Related]
14. The significance of immunochemically staining calcitonin and CEA in fine-needle aspiration biopsy materials from medullary carcinoma of the thyroid. Takeichi N; Ito H; Okamoto H; Matsuyama T; Tahara E; Dohi K Jpn J Surg; 1989 Nov; 19(6):674-8. PubMed ID: 2607690 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. Saad MF; Fritsche HA; Samaan NA J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192 [TBL] [Abstract][Full Text] [Related]
16. Imaging of colon carcinoma with 111-indium-labeled anti-CEA monoclonal antibodies (Indacea) prior to surgery. Beatty JD; Philben VJ; Beatty BG; Williams LE; Paxton RJ; Shively JE; Duda RB; Vlahos WG; Werner JL; Sheibani K J Surg Oncol; 1987 Oct; 36(2):98-104. PubMed ID: 3657182 [TBL] [Abstract][Full Text] [Related]